Persistent or recurrent hyperparathyroidism in patients with double adenomas*
References (26)
- et al.
Initial failure of surgical exploration in patients with hyperparathyroidism
Am J Surg
(1990) - et al.
Hyperparathyroidism problems in surgical management
Am J Surg
(1982) - et al.
Reoperation for persistent and recurrent hyperparathyroidism
Ann Surg
(1985) - et al.
Clinical management of persisten and/or recurrent hyperparathyroidism
World J Surg
(1986) - et al.
Strategy in reoperative surgery for hyperparathyroidism
Arch Surg
(1989) - et al.
The reasons for failure in parathyroid operations
Arch Surg
(1989) - et al.
A density test for the intraoperative differentiation of parathyroid hyperplasia from neoplasms
Ann Surg
(1978) - et al.
Double parathyroid adenomas: clinical and biochemical characteristics
Ann Surg
(1993) - et al.
Subtotal parathyroidectomy for primary hyperparathyroidism
Arch Surg
(1983) - et al.
Hyperparathyroidism associated with the enlargement of two or three parathyroid gland
Ann Surg
(1985)
Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited: Where are we in the early 1990s? A plea against unilateral parathyroid exploration
Surgery
Recurrent hyperparathyroidism
Ann Surg
Primary hyperparathyroidism associated with two enlarged parathyroid glands
Arch Surg
Cited by (29)
Persistent/Recurrent Primary Hyperparathyroidism: Does the Number of Abnormal Glands Play a Role?
2020, Journal of Surgical ResearchThe truth about double adenomas: Incidence, localization, and intraoperative parathyroid hormone
2016, Journal of the American College of SurgeonsMolecular Basis of Primary Hyperparathyroidism
2015, The Parathyroids: Basic and Clinical Concepts: Third EditionRecurrent and persistence primary hyperparathyroidism occurs more frequently in patients with double adenomas
2014, Journal of Surgical ResearchCitation Excerpt :PHPT is caused by a single adenoma (SA) in around 80%–85% of the cases and multigland disease in the form of double adenoma (DA), four-gland hyperplasia (HP) in around 15%–20% of the cases, or parathyroid carcinoma in fewer than 1% of cases [1–3]. Although some investigators think that DAs do not exist and instead represent cases of asymmetrical four-gland hyperplasia [4], other investigators recognize DA as a separate clinical entity [5–7]. Although the actuality of parathyroid DAs is still controversial [2,8], it now generally is agreed that DA do exist as a separate clinical entity [5,9].
Imaging of Thyroid and Parathyroid Glands
2013, Seminars in RoentgenologyTwice-recurrent primary hyperparathyroidism due to parathyroid hyperplasia in an ectopic supernumerary gland
2006, Endocrine PracticeCitation Excerpt :Some patients, however, experience recurrent disease after a period of normocalcemia following initial surgical treatment. Several studies have reported success rates for reoperation due to recurrent or persistent HPT of 88% to 95% (3-7). Nevertheless, only a few studies have reported long-term follow-up after reoperation.
- *
Supported in part by Mount Zion Health Systems, the Ben Shane Fund, and the Medical Research Service of the Veterans Affairs Medical Center.
Presented at the Sixteenth Annual Meeting of the American Association of Endocrine Surgeons, Philadelphia, Pa., April 23–25, 1995.
- a
Was Fellow in Endocrine Surgery and is currently at the Department of Surgery, Istanbul Faculty of Medicine, Istanbul, Turkey.